Defziff 24 Tablet contains Deflazacort 24 mg, a corticosteroid with potent anti-inflammatory and immunosuppressive properties. It is used for managing autoimmune disorders, chronic inflammatory conditions, and severe allergies, reducing tissue inflammation and immune overactivity.
Clinically, Deflazacort works by modulating the immune response and decreasing pro-inflammatory mediators, providing relief from symptoms such as joint pain, swelling, and allergic reactions. Its efficacy and tolerability make it suitable for long-term management under medical supervision.
The tablet formulation ensures accurate dosing, ease of administration, and consistent therapeutic effect, supporting hospitals, clinics, and outpatient care in the treatment of chronic inflammatory and autoimmune conditions.
From a business perspective, Defziff 24 Tablet is a high-demand corticosteroid, offering franchise partners strong market presence, repeat orders, and credibility in anti-inflammatory therapy.